ReviewInternational journal of molecular sciences2024

Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature.

Lampros G Chrysavgis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.